GSK long-standing commitment to clinical study transparency
We recognise the importance of publicly disclosing clinical research on our medicines.
GSK Study Register
In 2004 we introduced the GSK Study Register a place where anyone can access information about the clinical research we carry out on our medicines. We were the first pharmaceutical company to do this.
GSK transparency position
Our clinical study results are made public regardless of whether they are positive or negative for our medicines. When a study begins we post a protocol summary, which includes the study’s objectives and design. Once the study has completed, we provide a summary of the results. We also disclose full protocols, statistical analysis plans, clinical study reports, regulatory overview documents and list studies for data sharing.
